Dr. Muhammed Majeed to Present on the Science of Ayurveda
PISCATAWAY, N.J., May 24, 2006 - Dr. Muhammed Majeed, founder and CEO of Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, will be presenting at the Indian Expo, an exhibition organized by India’s department of AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy) being held in conjunction with the World Health Organization's annual World Health Assembly. Dr. Majeed will discuss the origins of Ayurveda and Ayurveda in the context of western medical science, as well as highlight clinical research surrounding several herbs traditionally used in Ayurvedic medicine as part of the inaugural day of the exhibition being held May 24 - 26, 2006, at the Hotel Intercontinental in Geneva, Switzerland.
"I am honored that the government of India has asked me to discuss the strengths and scientific basis of Ayurveda as part of this important global health event," stated Majeed. "This is a great opportunity for India to showcase Ayurveda to the world, especially as traditional Indian medicines are gaining worldwide acceptance as part of emerging natural health practices."
Muhammed Majeed was born and raised in Kerala, India. He emigrated to the United States in 1975, shortly after graduating with a degree in pharmacy from Kerala University. Upon arriving in the United States, Majeed began working for top pharmaceutical companies including Pfizer, Inc., Carter Wallace and Paco Research in progressively responsible research positions. He also continued his graduate studies, receiving his Ph.D. in Industrial Pharmacy from St. John's University, New York in 1986. In 1988, Dr. Majeed founded Sabinsa Corporation, a company that has brought to market more than 30 standardized botanical extracts, several of which are derived from Indian based plant materials, for use in various supplements and products. Additionally, he established SAMI Labs Ltd., a research group and manufacturing facility located in India that operates in conjunction with Sabinsa to develop nutraceuticals and fine chemicals.
The World Health Assembly, which meets annually in Geneva, is the decision-making body for the World Health Organization. The Assembly is attended by delegations from all 192 Member States to determine the policies of the organization. This year, issues to be discussed include: strengthening pandemic-influenza preparedness and response, including the application of the International Health Regulations 2005; infant and young child nutrition; HIV/AIDS; polio eradication; sickle-cell anemia; smallpox eradication and the destruction of variola virus stocks; prevention of avoidable blindness; international trade and health; tobacco control; and intellectual property rights. For more information visit www.who.int/en.
Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals. Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being.
Over the past nine years, Sabinsa has brought to market more than 30 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified
Kosher. For more information visit www.sabinsa.com.
# # #